188 related articles for article (PubMed ID: 10951154)
21. Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
Chen CC; Teng CL; Yeh SP
Ann Hematol; 2016 Apr; 95(5):837-40. PubMed ID: 26873089
[No Abstract] [Full Text] [Related]
22. Indolent subcutaneous panniculitis-like T cell lymphoma in a 1-year-old child.
Kawachi Y; Furuta J; Fujisawa Y; Nakamura Y; Ishii Y; Otsuka F
Pediatr Dermatol; 2012; 29(3):374-7. PubMed ID: 22122828
[TBL] [Abstract][Full Text] [Related]
23. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
24. High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Nastoupil LJ; McLaughlin P; Feng L; Neelapu SS; Samaniego F; Hagemeister FB; Ayala A; Romaguera JE; Goy AH; Neal E; Wang M; Fayad L; Fanale MA; Oki Y; Westin JR; Rodriguez MA; Cabanillas F; Fowler NH
Br J Haematol; 2017 Apr; 177(2):263-270. PubMed ID: 28340281
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
Rojnuckarin P; Nakorn TN; Assanasen T; Wannakrairot P; Intragumtornchai T
Leuk Lymphoma; 2007 Mar; 48(3):560-3. PubMed ID: 17454599
[TBL] [Abstract][Full Text] [Related]
26. Subcutaneous panniculitic T-cell lymphoma in childhood: successful response to chemotherapy.
Thomson AB; McKenzie KJ; Jackson R; Wallace WH
Med Pediatr Oncol; 2001 Dec; 37(6):549-52. PubMed ID: 11745897
[No Abstract] [Full Text] [Related]
27. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
Luo SK; Li J; Hong WD; Zhao Y; Tong XZ
Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous lymphomas with a panniculitic presentation.
Willemze R
Semin Diagn Pathol; 2017 Jan; 34(1):36-43. PubMed ID: 27986433
[TBL] [Abstract][Full Text] [Related]
29. Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis.
Lester L; Ewalt M; Warnke R; Kim J
J Cutan Pathol; 2015 Jan; 42(1):46-9. PubMed ID: 25384366
[TBL] [Abstract][Full Text] [Related]
30. Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).
Keating MJ; McLaughlin P; Cabanillas F
Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):21-6. PubMed ID: 9460339
[TBL] [Abstract][Full Text] [Related]
31. Subcutaneous T-cell lymphoma: report of two cases.
Wasik F; Kołodziej T; Jeleń M; Pejcz J
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):62-6. PubMed ID: 9552760
[TBL] [Abstract][Full Text] [Related]
32. Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
McLaughlin P; Hagemeister FB; Swan F; Cabanillas F; Pate O; Romaguera JE; Rodriguez MA; Redman JR; Keating M
J Clin Oncol; 1994 Mar; 12(3):575-9. PubMed ID: 8120556
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Tsimberidou AM; Younes A; Romaguera J; Hagemeister FB; Rodriguez MA; Feng L; Ayala A; Smith TL; Cabanillas F; McLaughlin P
Cancer; 2005 Jul; 104(2):345-53. PubMed ID: 15948158
[TBL] [Abstract][Full Text] [Related]
34. Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
Tse E; Chan JC; Pang A; Au WY; Leung AY; Lam CC; Kwong YL
Leukemia; 2007 Oct; 21(10):2225-6. PubMed ID: 17525720
[No Abstract] [Full Text] [Related]
35. A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.
Scarisbrick JJ; Child FJ; Clift A; Sabroe R; Whittaker SJ; Spittle M; Russell-Jones R
Br J Dermatol; 2001 May; 144(5):1010-5. PubMed ID: 11359390
[TBL] [Abstract][Full Text] [Related]
36. Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.
McLaughlin P; Hagemeister FB; Rodriguez MA; Sarris AH; Pate O; Younes A; Lee MS; Dang NH; Romaguera JE; Preti AH; McAda N; Cabanillas F
Semin Oncol; 2000 Dec; 27(6 Suppl 12):37-41. PubMed ID: 11225999
[TBL] [Abstract][Full Text] [Related]
37. A Japanese case of typical epstein-barr virus non-associated subcutaneous panniculitis-like T-cell lymphoma.
Sugita K; Kobayashi M; Hino R; Ohta T; Ohshima K; Tokura Y
J Dermatol; 2004 Mar; 31(3):253-4. PubMed ID: 15187351
[No Abstract] [Full Text] [Related]
38. Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.
Shin DY; Kim SJ; Yoon DH; Park Y; Kong JH; Kim JA; Kim BS; Kim HJ; Won JH; Park SK; Kim WS
Cancer Chemother Pharmacol; 2016 Apr; 77(4):865-73. PubMed ID: 26984211
[TBL] [Abstract][Full Text] [Related]
39. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
McLaughlin P; Hagemeister FB; Romaguera JE; Sarris AH; Pate O; Younes A; Swan F; Keating M; Cabanillas F
J Clin Oncol; 1996 Apr; 14(4):1262-8. PubMed ID: 8648382
[TBL] [Abstract][Full Text] [Related]
40. Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine.
Go RS; Gazelka H; Hogan JD; Wester SM
Ann Hematol; 2003 Apr; 82(4):247-50. PubMed ID: 12707730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
